🔴 Lantern Pharma is trading 8.8% down; no company-specific catalyst identified

Lantern Pharma is trading 8.81% down at $0.53, with no company-specific announcement explaining the November 5 decline identified.

• The latest company news found was from October; the reported October offering is not a new catalyst.
• The broader market is sharply lower and may be contributing: the Nasdaq is down 3.90% and the S&P 500 is down 2.43%. This does not establish a direct cause.